Zenith Healthcare Q3 FY26 turnaround: profit up

Key update at a glance

Zenith Healthcare Limited, trading on the BSE under the ticker ZENITHHE, has reported a notable improvement in its latest quarterly performance. In Q3 FY26, the company posted revenue of ₹2.48 crore, up 7.7% year-on-year (YoY), along with a net profit of ₹0.22 crore. The quarter stands out because it indicates a turnaround in profitability even as the business continues to face longer-term growth constraints.

The company operates in the Health technology segment and is classified as Pharmaceuticals: Other. It is based in Ahmedabad, Gujarat, and is engaged in manufacturing and trading pharmaceutical formulations.

Company profile and business mix

Zenith Healthcare is described as an Ahmedabad-based pharmaceutical company focused on the manufacturing and trading of formulations. Its product forms include tablets, capsules, and injectables, serving multiple therapeutic areas. The company also references contract manufacturing services, positioning itself as both a manufacturer and a supply partner.

The disclosures provided include two different founding references: it is stated as founded on Apr 27, 1995, and also described as formed in 1994. In practical terms, the company has a multi-decade operating history and is part of Gujarat’s broader pharmaceutical ecosystem.

FY2024 numbers: small base, steady profitability

For FY2024, Zenith Healthcare reported:

• Net sales: ₹14.47 crore
• Net profit: ₹0.20 crore

These figures suggest a relatively small revenue base and thin profitability for the year. With small absolute profits, even moderate operating shifts can materially change quarterly outcomes. The FY2024 data also sets the context for why Q3 FY26 profitability is being seen as a meaningful development.

Q3 FY26 results: revenue up 7.7% YoY, profit at ₹0.22 crore

The latest reported performance for Q3 FY26 shows:

• Revenue: ₹2.48 crore, up 7.7% YoY
• Net profit: ₹0.22 crore

The company’s Q3 FY26 net profit is notable because it is larger than the full-year FY2024 profit number reported in the same dataset, highlighting how quarter-to-quarter execution can reshape the headline picture for a smaller company.

The update also mentions “improving operational efficiency,” while simultaneously flagging “long-term growth challenges.” Read together, it indicates near-term execution has improved, but the company still needs to address durability and scale.

Strategic linkage with Achyut Healthcare: facility agreement in early 2025

One of the most concrete strategic developments mentioned is a strategic linkage with Achyut Healthcare Limited. The information provided says:

• Zenith Healthcare’s management has an association with Achyut Healthcare.
• The two companies signed a facility agreement in early 2025.
• The agreement duration is stated as 9 years.
• The stated goal is resource integration to expand commercialisation capacity.

While the dataset does not quantify the capacity expansion or provide capex details, the existence of a long-duration facilities arrangement signals a structured attempt to support operations through shared resources and an extended planning horizon.

Locations and operating footprint

Zenith Healthcare’s listed presence is anchored in Ahmedabad, Gujarat, near a major pharmaceutical hub. The information provided includes multiple addresses:

• Registered and Corporate Office: 504, Iscon Elegance, Nr. Shapath 5, S.G. Road, Ahmedabad-380015
• Works: 388/34, Changodar Industrial Estate, Sarkhej-Bawla Highway, Changodar-382 213, Dist. Ahmedabad
• Kolkata address: Ground Floor, Kanak Villa, E/94/1, Nr. Ramkishan Asharam, Baghajatin, Kolkata, West Bengal 700086
• Agent information (Mumbai): Marol, Andheri (East), Mumbai 400059, Maharashtra

The company website is listed as http://www.zenithhealthcare.com.

Management note: professional leadership reference

The dataset also notes that Zenith Healthcare is a listed public limited company managed by a professional Chartered Accountant with 20 years of experience. No additional leadership names or governance specifics are provided in the source text, but the statement is positioned as a credibility and stewardship point.

What the numbers could imply for investors

With Q3 FY26 revenue growth and a positive net profit, the immediate implication is that operational performance has improved compared with the prior-year quarter. For a company with FY2024 profit of ₹0.20 crore, even a modest lift in quarterly profitability can alter how investors perceive execution.

At the same time, the company’s scale remains limited in absolute terms, and the update explicitly mentions longer-term growth challenges. For market participants, the key practical question becomes whether the improvement is repeatable over subsequent quarters and whether the operational setup, including the 9-year facility agreement, supports steady utilisation and supply capability.

Snapshot table: key disclosed facts

Conclusion

Zenith Healthcare’s Q3 FY26 performance shows a clear improvement, with 7.7% YoY revenue growth to ₹2.48 crore and a net profit of ₹0.22 crore. FY2024 numbers, including ₹14.47 crore in net sales and ₹0.20 crore in net profit, underline both the company’s small scale and how meaningful quarterly execution can be. The 9-year facility agreement signed in early 2025 with Achyut Healthcare adds an operational angle worth tracking as the company works to strengthen commercial capacity.